1.
Real-world data on the incidence of immune-related adverse events associated with anti-PD-1/PD-L1 treatment in Russia. Вопр. онкол. [Internet]. 2022 May 6 [cited 2026 Oct. 14];68(2):188-99. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/1378